Folium Ginkgo extract and tetramethylpyrazine sodium chloride injection (Xingxiong injection) protects against focal cerebral ischaemia/reperfusion injury via activating the Akt/Nrf2 pathway and inhibiting NLRP3 inflammasome activation

Abstract

Context Folium Ginkgo extract and tetramethylpyrazine sodium chloride injection (Xingxiong injection) is a compound preparation commonly used for treating cerebral ischaemia/reperfusion injury in ischaemic stroke in China. However, its potential mechanisms on ischaemic stroke remain unknown. Objective This study explores the potential mechanisms of Xingxiong injection in vivo or in vitro. Materials and methods Sprague-Dawley (SD) rats were randomly assigned to five groups: the sham (normal saline), the model (normal saline) and the Xingxiong injection groups (12.5, 25 or 50 mL/kg). The rats were subjected to 2 h of middle cerebral artery occlusion (MCAO) followed by reperfusion for 14 d. Xingxiong injection was administered via intraperitoneal (i.p.) injection immediately after ischaemia induction for 14 d. Afterwards, rats were sacrificed at 14 d induced by administration of Xingxiong injection. Results Xingxiong injection significantly reduces infarct volume (23%) and neurological deficit scores (93%) compared with the MCAO/R group. Additionally, Xingxiong injection inhibits the loss in mitochondrial membrane potential (43%) and reduces caspase-3 level (44%), decreases NOX (41%), protein carbonyl (29%), 4-HNE (40%) and 8-OhdG (41%) levels, inhibits the expression of inflammatory factors, such as TNF-α (26%), IL-1β (34%), IL-6 (39%), MCP-1 (36%), CD11a (41%) and ICAM-1 (43%). Moreover, Xingxiong injection can increase p-Akt/Akt (35%) and Nrf2 (47%) protein expression and inhibit NLRP3 (42%) protein expression. Conclusions Xingxiong injection prevents cerebral ischaemia/reperfusion injury via activating the Akt/Nrf2 pathway and inhibiting NLRP3 inflammasome. These findings provide experimental evidence for clinical use of drugs in the treatment of ischaemic stroke.

Protective effects of Gypenoside XVII against cerebral ischemia/reperfusion injury via SIRT1-FOXO3A- and Hif1a-BNIP3-mediated mitochondrial autophagy

“…ELISA kits were used according to the manufacturer’s instructions and a previously described method [ 12 , 46 ] to quantify IL-6, TNF-α, MCP-1, T-AOC and 4-HNE in serum.…”

Treatment of Ischemic Stroke With Wenyang Huayu Formula: Network Pharmacology Analysis and Experimental Validation

“…We used previously reported information to explore the mechanism of TCM in the treatment of stroke. 7,8 Network pharmacology analysis was based on 277 compounds with potential biological activity, 2846 corresponding protein targets, and 3777 disease targets in WYHYF to construct a "drug-ingredient-target-disease" network. Pathway enrichment analysis suggested that inflammation is closely related to cerebral ischemia-reperfusion, and the inflammatory signaling pathway may play an important role in treating cerebral ischemia-reperfusion using WYHYF.…”

“…We used previously reported information to explore the mechanism of TCM in the treatment of stroke. 7,8…”

Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review

“…The PI3K/Akt pathway activation can promote Nrf2 nuclear translocation ( Martin et al, 2004 ; Zhai et al, 2018 ). TMP sodium chloride injection was reported to enhance the expression of HO-1 by activating the PI3K/Akt/Nrf2 signal pathway ( Zhu et al, 2022 ). At the same time, the expression levels of IL-1β, caspase-1, and NOD-like receptors family pyrin domain containing 3 (NLRP3) were significantly decreased by the treatment of TMP sodium chloride injection ( Zhu et al, 2022 ).…”